Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer
Abstract
Breast tumors harbor dynamic microenvironments, with multiple immune cell types playing opposing roles during tumor progression and/or response to therapy. Tumor-associated macrophages promote mammary tumorigenesis, whereas the role of mammary tissue macrophages (MTMs) remains incompletely understood. High-dimensional immunostaining of murine mammary tumor progression revealed that MTMs were localized in the peritumoral stroma and associated with eosinophils, which were previously shown to facilitate antitumor T cell responses. The depletion of MTMs accelerated tumorigenesis in both spontaneous and orthotopically transplanted mammary tumor models. Upon induction of a productive antitumor response via the depletion of regulatory T cells, MTMs assumed an alternatively activated state and expressed eotaxins, thereby attracting eosinophils to peritumoral regions. MTMs expressed the receptor for the alarmin IL-33, which induced both MTM activation and eosinophil recruitment. These results suggest that MTMs can sense IL-33 and recruit eosinophils to facilitate antitumor immunity, a mechanism that may operate during tumor progression and be further enhanced during productive antitumor responses.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
Joseph Saglimbeni
Department of Pathology, New York University Grossman School of Medicine
Eduardo Esteva
Department of Pathology, New York University Grossman School of Medicine
Josue Canales
Department of Pathology, New York University Grossman School of Medicine
Oriana A. Perez
Department of Pathology, New York University Grossman School of Medicine
Anna Eichinger
Department of Pathology, New York University Grossman School of Medicine
William Huntley
Department of Pathology, New York University Grossman School of Medicine
Kamal M. Khanna
Igor Dolgalev
Applied Bioinformatics Laboratories, New York University Grossman School of Medicine
Natalie Klar
Perlmutter Cancer Center, New York University Grossman School of Medicine
Sylvia Adams
Perlmutter Cancer Center, New York University Grossman School of Medicine
Boris Reizis